Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced the appointment of Steve Sabus to the role of Chief Commercial Officer (CCO), effective December 5, 2022. Mr. Sabus brings ...
Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of veterinary MedTech leader Movora, an operating company of Vimian. Colleen assumes her position on December 1 and succeeds Patrick Gendreau and Christopher Sidebotham who have decided to step down. Colleen ...
Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin Duato, to assume the additional position of Chairman, effective in January 2023. Mr. Duato succeeds Mr. Alex Gorsky, who will ...
Popular Posts
